Becton, Dickinson and Co. news

   Watch this stock
Showing stories 1 - 10 of about 39   

Articles published

BDX 151.17 +1.29 (0.86%)
price chart
Recent cases show that utilitarian functionality is a serious – and common ...
In other words, courts may consider whether alternative product designs are available, and whether the cost or time involved in using an alternative design makes it impractical.
Asuragen Grants Armored RNA� Technology License to BD
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc. announced today that it has granted BD (Becton, Dickinson and Company), a global medical technology company, non-exclusive worldwide rights to incorporate Armored RNA� technology into its in vitro ...
JDRF, BD Expand Diabetes Collaboration to Develop Continuous Glucose ...
Diabetes research organization JDRF and Becton, Dickinson and Company (BD) have extended their existing type 1 diabetes collaboration to include further development of the latter's next-generation continuous glucose-sensing platform.
New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of ...
SAN JOSE, Calif., June 23, 2012 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the BD FACSJazz™ Cell Sorting System, a next-generation flow cytometer that simplifies ...
Talent Development Reporting: An Evolving Standard for L&D
... professor emeritus, Western Michigan University; Jack Phillips, chairman, ROI Institute; Josh Bersin, CEO and president, Bersin & Associates; Frank Anderson, president, Strategic Public Sector Solutions LLC; and Laurie Bassi, CEO of McBassi & Co.
Eric Schoenstein: High Growth Stock Picks With Quality Management
Becton, Dickinson and Company (BDX, Earnings, Analysts, Financials): Develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide.
Inequitable conduct remains a powerful tool for retailers after Therasense
After the Federal Circuit's 2011 decision in Therasense Inc. v. Becton, Dickinson and Co., many practitioners thought that holding patents unenforceable based upon inequitable conduct before the Patent Office was all but dead.
IPO Releases List of Top 300 Patent Holders for 2011
Life sciences companies and organizations that failed to make the IPO top 300 in 2011 after making it in 2010 included Boehringer Ingelheim International GmbH (#260 on the IPO top 300 for 2010), Becton, Dickinson and Co. (263), Columbia University (272 ...
Microfluidics-based point-of-care testing market to reach $16B in 2017
Companies cited in the report include 3M, Abaxis, Abbott Point of Care, Accumetrics, Akonni Biosystems, Alere, Amic, Axis Shield POC, Becton, Dickinson and Co, Bio‐Rad, BioCartis, CD4 Initiative Test, Cepheid, Chempaq, Curetis, Daktari, DNA electronics ...
DaVita to Cut Energy Use 15% Per Treatment by 2015
Dialysis provider DaVita Inc. plans to cut its energy consumption 15 percent per treatment by 2015 as part of a larger environmental initiative.